article thumbnail

Join HCCA for the 28th Annual Compliance Institute

ACRP blog

Few industries have a need to understand the complexities of compliance more than clinical research. The importance of compliance in clinical research cannot be stressed enough. This year’s Compliance Institute features more than 100 educational sessions across 14 unique learning tracks.

article thumbnail

Hyman, Phelps & McNamara, P.C. (HP&M) is Pleased to Announce the Addition of Sara M. Keup as the new State Licensing Regulatory Expert for the Firm’s Licensing Practice

FDA Law Blog

HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AB Science announces Canadian patent for masitinib to treat ALS

Pharmaceutical Technology

Under the notice of compliance with conditions (NOC/c) policy, AB Science received authorisation from Health Canada to file a new drug submission for masitinib to treat ALS. This helps to prevent generic competition for eight years after initial approval. According to AB Science, approximately 3,000 Canadians are now living with ALS.

article thumbnail

Transforming Clinical Trial Management: The Shift from Point Systems to Platform Solutions

Cloudbyz

The landscape of clinical trial management is undergoing a significant transformation, driven by the complex demands of modern medical research. Participants may have to navigate through multiple platforms for different phases of the trial, while researchers and sponsors juggle various interfaces to access the data and insights they need.

article thumbnail

Cannabis Advocates High On Recent Medical Marijuana Research Legislation

FDA Law Blog

The enactment of the Medical Marijuana and Cannabidiol Research Expansion Act (“the Act”) into law (Public Law 117-215) last month is a step in that direction. Federal Research. The Act places the onus on DEA to ensure an adequate, uninterrupted supply of cannabis for research. President Biden signed the law on December 2nd.

article thumbnail

Comparing Cloudbyz Safety & PV Solution with Other Pharmacovigilance Solutions: A Comprehensive Analysis

Cloudbyz

In the dynamic realm of pharmacovigilance, where safety and compliance are paramount, choosing the right solution can profoundly impact operational efficiency and patient well-being. Moreover, it provides a user-based license structure, dedicated mobile access, robust data security, and the ability to support different regions and domains.

article thumbnail

The Paleo Diet Launches a Paleo Certification Program for Food Packaging

XTalks

Based on the science from the researchers who established the framework of modern Paleolithic nutrition, the program aims to provide guidance for the food industry by codifying Paleo Diet standards and making them available to manufacturers, retailers and other partners.